This is not the most recent version of the article. View current version (28 MAY 2014)

Intervention Protocol

You have free access to this content

Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department

  1. Kayleigh M Kew1,*,
  2. Liza Kirtchuk1,
  3. Clare I Michell1,
  4. Benedict Griffiths2

Editorial Group: Cochrane Airways Group

Published Online: 29 JAN 2014

DOI: 10.1002/14651858.CD010909


How to Cite

Kew KM, Kirtchuk L, Michell CI, Griffiths B. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD010909. DOI: 10.1002/14651858.CD010909.

Author Information

  1. 1

    St George's, University of London, Population Health Sciences and Education, London, UK

  2. 2

    St Thomas' Hospital, Evelina Children's Hospital, London, UK

*Kayleigh M Kew, Population Health Sciences and Education, St George's, University of London, Cranmer Terrace, London, SW17 0RE, UK. kkew@sgul.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 29 JAN 2014

SEARCH

This is not the most recent version of the article. View current version (28 MAY 2014)

 
Table 1. Summary of guideline treatment recommendations in acute asthma

BTS/SIGNGINANACANAEPP

Oxygen

Inhaled beta2-agonist

Inhaled antimuscarinic

Sytemic steroids

IV beta2-agonist(✓)

if nebulised form cannot be used

reliably
x

if no response to inhaled form
x

IV magnesium sulfate

IV or nebulised

Helioxxxx

IV aminophylline/theophylline(✓)

limited evidence, only after senior consultation
(✓)

if inhaled beta2-agonist unavailable
(✓)

as an alternative to IV beta2-agonist
x

 BTS/SIGN = British Thoracic Society & Scottish Intercollegiate Guidelines Network joint guideline; GINA = Global Initiative for Asthma; IV = intravenous; NACA = National Asthma Council Australia; NAEPP= National Asthma Education and Prevention Program